NovoCure LimitedCompany Review & Valuation

NVCR
Nasdaq
Latest Price
132.34USD
Market Capitalization
13.10bUSD

About NovoCure Limited

NovoCure Limited engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) for the treatment of solid tumors. The company markets its proprietary therapy, TTFields delivery system under the Optune name for use as a monotherapy treatment for adult patients witShow moreh glioblastoma brain cancer. It is also involved in conducting clinical trials for the use of TTFields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer, and mesothelioma. The company markets its products in the United States, Germany, Switzerland, Japan, and other countries. NovoCure Limited was founded in 2000 and is based in Saint Helier, the Channel Islands.Show less

Industry
HQ Location
Saint Helier, the Channel Islands

Stock Price

Price data not available for NovoCure Limited.

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

Sun Life Financial
Tractor Supply Company
Qiagen
Avista

back to top